SCHEMBL633340

SCHEMBL633340

FC(F)C(F)(F)ONc1ccccc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 2/20 0.34
ALDH1A1 P00352 5/20 0.33
TDP1 Q9NUW8 4/20 0.33
HSD17B10 Q99714 2/20 0.33
CTSD P07339 1/20 0.33
MAPT P10636 2/20 0.32
TSHR P16473 3/20 0.32
PTGS2 P35354 2/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
PTGS1 P23219 1/20 0.32
SLC6A2 P23975 1/20 0.32
MAPK1 P28482 1/20 0.32
HTR2B P41595 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
IDO1 P14902 2/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10583635 0.84 LMNA (0.38) CFTRALDH1A1TDP1HSD17B10CTSD
SCHEMBL10585379 0.84 ALDH1A1 (0.38) CFTRALDH1A1TDP1HSD17B10CTSD
SCHEMBL742856 0.78 ALDH1A1 (0.39) ALDH1A1TDP1HSD17B10CTSDMAPT
SCHEMBL15391808 0.74 ALDH1A1 (0.36) ALDH1A1TDP1HSD17B10CTSDMAPT
SCHEMBL50027 0.73 TSHR (0.42) ALDH1A1TDP1HSD17B10CTSDMAPT
SCHEMBL2493371 0.72 ALDH1A1 (0.35) ALDH1A1TDP1HSD17B10CTSDMAPT
Hydrochloric Acid SCHEMBL28777083 0.71 TSHR (0.40) ALDH1A1TDP1HSD17B10CTSDMAPT
SCHEMBL9225004 0.71 ALDH1A1 (0.37) ALDH1A1TDP1HSD17B10CTSDMAPT
SCHEMBL10586608 0.71 ALDH1A1 (0.33) ALDH1A1TDP1HSD17B10CTSDMAPT
Toluene SCHEMBL27973589 0.69 TSHR (0.44) ALDH1A1TDP1CTSDMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8586617-B2 Aminomethyl-4-imidazoles HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2076497-B1 AMINOMETHYL-4-IMIDAZOLES HOFFMANN LA ROCHE (CH) 2012-02-22 EP disclosed
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-22 US disclosed
EP-1187816-B1 5-CYANO-2-AMINOPYRIMIDINE DERIVATIVES CELLTECH R&D LTD (GB) 2006-12-20 EP disclosed
US-20040180914-A1 5-Cyano-2-aminopyrimidine derivatives CELLTECH R&D LIMTIED 2004-09-16 US disclosed
US-6579983-B1 Potent and selective inhibitors of receptor tyrosine kinases involved in angiogenesis, especially KDR kinase and/or FGFr kinase CELLTECH R&D LIMITED (GB) 2003-06-17 US disclosed
US-20020147339-A1 5-cyano-2-aminopyrimidine derivatives CELLTECH R&D LIMITED (GB) 2002-10-10 US disclosed
EP-0241834-A2 Use of 3-carbamoyl-4-hydroxy-cumarines in combating parasiticidal helminths, 3-carbamoyl-4-hydroxy-cumarines and their preparation BAYER AG (DE) 1987-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES INMT, HTR4, MC4R CFTR 2916/4885ALDH1A1 631/4885TDP1 1506/4885
US-20040180914-A1 5-Cyano-2-aminopyrimidine derivatives FLT1, FGFR1, KDR CFTR 3133/4885ALDH1A1 873/4885TDP1 1237/4885
US-20020147339-A1 5-cyano-2-aminopyrimidine derivatives FLT1, FGFR1, KDR CFTR 3132/4885ALDH1A1 859/4885TDP1 1231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.